Tesamorelin Peptide

Tesamorelin is a synthetic peptide analogue of growth hormone-releasing hormone (GHRH). It has attracted significant scientific interest due to its interaction with GHRH receptors and its association with endocrine signalling pathways. It is frequently examined in studies exploring hormonal regulation mechanisms and biological communication systems.

Researchers have investigated Tesamorelin across a variety of experimental models involving endocrine signalling, metabolic regulation, and peptide-receptor interactions. Its well-characterised structure has made it a widely referenced compound within peptide and neuroendocrine research literature.

Research Overview

Tesamorelin is commonly studied in relation to:

• Growth hormone-releasing hormone (GHRH) receptor investigations
• Endocrine and neuroendocrine signalling research
• Hormonal regulatory pathway studies
• Peptide-receptor interaction research
• Metabolic signalling mechanism investigations
• Cellular communication and biological regulation studies

As a synthetic GHRH analogue, Tesamorelin continues to be examined in research focused on endocrine communication networks and complex biological signalling pathways.

Key Characteristics

• Synthetic analogue of growth hormone-releasing hormone (GHRH)
• Purity ≥98% (HPLC verified)
• Supplied as lyophilised powder
• Frequently studied in endocrine and hormonal signalling research
• Suitable for laboratory and scientific research applications

Product Specifications

• Available quantities: 2mg, 10mg, and 20mg
• Lyophilised powder format
• Purity ≥98% (HPLC verified)
• Store in a cool, dry place
• Reconstituted solutions should be refrigerated

Important Information

• Supplied for research purposes only
• Not for human or veterinary use
• Not intended for consumption
• This product is not intended to diagnose, treat, cure, or prevent any disease
• Purchasers are responsible for ensuring compliance with local laws and regulations